Pathomorphological brain changes due to coronavirus disease 2019 (COVID-19)
DOI:
https://doi.org/10.14739/2310-1237.2025.2.334783Keywords:
COVID-19, SARS-CoV-2 virus, brain, neurological complications, stroke, hemorrhage, encephalopathy, astrocytes, GFAP, CD68, microglia, CD3, T-lymphocytes, pathomorphology, immunohistochemistryAbstract
Aim: To investigate the pathomorphological changes in the brains of individuals who died from complications of coronavirus disease (COVID-19) and to identify the neuropathological features associated with COVID-19.
Materials and methods. A morphological study was conducted on autopsy material from 78 individuals who died due to complications of COVID-19 between March 2020 and April 2021. Histological examinations of various brain regions – including the cortex, white matter, basal ganglia, hippocampus, brainstem, and cerebellum – were performed using both morphological and immunohistochemical methods. Monoclonal antibodies were used to detect astrocytes (GFAP, Thermo Scientific), microglia (CD68, Clone Ab-4, Thermo Scientific), and T-lymphocytes (CD3, Clone SP7, Thermo Scientific). Histological evaluation and microphotography were carried out using a Leica DM750 universal optical microscope (Leica Microsystems GmbH).
Results. It was found that brain damage in hospitalized patients with SARS-CoV-2 infection was associated with older age, disease severity, and comorbidities. In cases of severe COVID-19 with neurological deficits, neurovascular incidents were accompanied by ischemic infarction, venous sinus thrombosis, and intracerebral hemorrhage. Hypoxic-ischemic encephalopathy was histologically characterized by degeneration and partial loss of neurons, microglial activation with the formation of numerous microglial nodules in the cortex around hypoxically altered neurons, in the white matter, perivascularly, and in perivascular spaces throughout different parts of the brain, reactive astrogliosis with a positive immunohistochemical marker GFAP, and perivascular infiltration by T-lymphocytes.
Conclusions. Since SARS-CoV-2 has a broad tissue tropism, both respiratory and extrapulmonary complications can occur. The neuropathological features and findings in the studied cases with a severe course included neuronal degeneration, microglial activation, infiltration by CD3-positive T-lymphocytes, reactive astrogliosis, and, in some cases, macroscopic abnormalities such as fresh and old ischemic infarctions and hemorrhages.
References
Zozulya IS, Kareta SO, Volosovets AO, Zozulya AI, Bigun IJ. [Diagnosis and treatment of persistent viral infection and neuroinfections]. Ukrainskyi medychnyi chasopys. 2019;2(6):1-4. Ukrainian. doi: https://doi.org/10.32471/umj.1680-3051.134.169017
Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM. Neurologic Alterations Due to Respiratory Virus Infections. Front Cell Neurosci. 2018;12:386. doi: https://doi.org/10.3389/fncel.2018.00386
Wilson ME, Chen LH. Travellers give wings to novel coronavirus (2019-nCoV). J Travel Med. 2020;27(2):taaa015. doi: https://doi.org/10.1093/jtm/taaa015
Khan MS, Khasnabish S, Grosack N, Mathew K, Rajasri M, Stern R, et al. Acute Complications of COVID-19 With Lasting Damages: A Case of Severe Long-Term Sequelae in a Middle-Aged Female Post COVID-19. Cureus. 2022;14(5):e24694. doi: https://doi.org/10.7759/cureus.24694
Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93(1):250-6. doi: https://doi.org/10.1002/jmv.26232
de Souza Goncalves B, Sangani D, Nayyar A, Puri R, Irtiza M, Nayyar A, et al. COVID-19-Associated Sepsis: Potential Role of Phytochemicals as Functional Foods and Nutraceuticals. Int J Mol Sci. 2024;25(15):8481. doi: https://doi.org/10.3390/ijms25158481
Vincent JL. COVID-19: it's all about sepsis. Future Microbiol. 2021;16:131-3. doi: https://doi.org/10.2217/fmb-2020-0312
Maiese A, Passaro G, Matteis A, Fazio V, Raffaele R, Paolo MD. Thromboinflammatory response in SARS-CoV-2 sepsis. Med Leg J. 2020;88(2):78-80. doi: https://doi.org/10.1177/0025817220926915
Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol. 2020;16(11):636-44. doi: https://doi.org/10.1038/s41582-020-0398-3
Mishchenko TS, Mishchenko VM. [Neurological complications in patients with COVID-19]. Psykhiatriia, nevrolohiia ta medychna psykholohiia. 2021;(16):23-33. Ukrainian. doi: https://doi.org/10.26565/2312-5675-2021-16-03
Lisianiy MI, Pedachenko EG. COVID-19: infection and neurological complications. Ukrainian Neurosurgical Journal. 2022;28(1):3-9. doi: https://doi.org/10.25305/unj.243599
Feshchenko DI, Malyk SL, Shevnia MB. [Headache on the background of coronavirus infection: features of the clinical picture]. The Journal of V. N. Karazin Kharkiv National University, Series "Medicine". 2022;45:74-81. Ukrainian. doi: https://doi.org/10.26565/2313-6693-2022-45-08
Shmatko YV, Bondar OB, Stepanchenko KA. [Cerebrovascular disorders in patients with COVID-19]. Mizhnarodnyi medychnyi zhurnal. 2021;(1):67-72. Ukrainian. doi: https://doi.org/10.37436/2308-5274-2021-1-12
Aliberti A, Gasparro R, Mignogna M, Canfora F, Spagnuolo G, Sammartino G, et al. Unveiling the Oral Lesions, Dysgeusia and Osteonecrosis Related to COVID-19: A Comprehensive Systematic Review. J Clin Med. 2025;14(4):1267. doi: https://doi.org/10.3390/jcm14041267
Favas TT, Dev P, Chaurasia RN, Chakravarty K, Mishra R, Joshi D, et al. Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions. Neurol Sci. 2020;41(12):3437-70. doi: https://doi.org/10.1007/s10072-020-04801-y
Sampaio Rocha-Filho PA. Headache associated with COVID-19: Epidemiology, characteristics, pathophysiology, and management. Headache. 2022;62(6):650-6. doi: https://doi.org/10.1111/head.14319
Siow I, Lee KS, Zhang JJ, Saffari SE, Ng A. Encephalitis as a neurological complication of COVID-19: A systematic review and meta-analysis of incidence, outcomes, and predictors. Eur J Neurol. 2021;28(10):3491-502. doi: https://doi.org/10.1111/ene.14913
Zamani R, Pouremamali R, Rezaei N. Central neuroinflammation in Covid-19: a systematic review of 182 cases with encephalitis, acute disseminated encephalomyelitis, and necrotizing encephalopathies. Rev Neurosci. 2021;33(4):397-412. doi: https://doi.org/10.1515/revneuro-2021-0082
Ziablitsev DS, Kozyk M, Strubchevska K, Dyadyk OO, Ziablitsev SV. Lung Expression of Macrophage Markers CD68 and CD163, Angiotensin Converting Enzyme 2 (ACE2), and Caspase-3 in COVID-19. Medicina (Kaunas). 2023;59(4):714. doi: https://doi.org/10.3390/medicina59040714
Kuzyk J, Gavrilyuk O, Semko M, Ribun B, Arefyeva A. COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Lviv and Lviv Region. Proc Shevchenko Sci Soc Med Sci. 2022;69(2):29-39. doi: https://doi.org/10.25040/ntsh2022.02.02
Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY). 2020;12(7):6049-57. doi: https://doi.org/10.18632/aging.103000
Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, et al. Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med. 2020;2(8):1069-76. doi: https://doi.org/10.1007/s42399-020-00363-4
Stirling JW, Woods AE. Resin (plastic) embedding for microscopy and tissue analysis. In: Bancroft’s Theory and Practice of Histological Techniques. Elsevier; 2019. p. 96-113. doi: https://doi.org/10.1016/B978-0-7020-6864-5.00008-6
Liskina IV, Oleksynska OO, Kuzovkova SD, Zagaba LM. [Histological study of the localization, volume and "age" of fibrin masses in the course of pulmonary tuberculosis with different activity of the specific inflammatory process]. Bulletin of Morphology. 2015;21(1):91-5. Ukrainian. Available from: https://morphology-journal.com/index.php/journal/article/download/107/104
Magaki S, Hojat SA, Wei B, So A, Yong WH. An Introduction to the Performance of Immunohistochemistry. Methods Mol Biol. 2019;1897:289-98. doi: https://doi.org/10.1007/978-1-4939-8935-5_25
Nguyen T, editor. Immunohistochemistry: A technical guide to current practices. Cambridge, England: Cambridge University Press; 2022.
COVID-19 cases [Internet]. Datadot. [cited 2025 Sept 6]. Available from: https://data.who.int/dashboards/covid19/cases
Dallavalasa S, Tulimilli SV, Prakash J, Ramachandra R, Madhunapantula SV, Veeranna RP. COVID-19: Diabetes Perspective-Pathophysiology and Management. Pathogens. 2023;12(2):184. doi: https://doi.org/10.3390/pathogens12020184
Hanganu AR, Niculae CM, Dulămea AO, Moisă E, Constantin R, Neagu G, et al. The outcome and risk factors associated with central and peripheral nervous system involvement in hospitalized COVID-19 patients: a retrospective cohort study. Front Neurol. 2024;14:1338593. doi: https://doi.org/10.3389/fneur.2023.1338593
Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging (Albany NY). 2020;12(10):9959-81. doi: https://doi.org/10.18632/aging.103344
Nersesjan V, Amiri M, Lebech AM, Roed C, Mens H, Russell L, et al. Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up. J Neurol. 2021;268(9):3086-104. doi: https://doi.org/10.1007/s00415-020-10380-x
Ousseiran ZH, Fares Y, Chamoun WT. Neurological manifestations of COVID-19: a systematic review and detailed comprehension. Int J Neurosci. 2023;133(7):754-69. doi: https://doi.org/10.1080/00207454.2021.1973000
Chernii VI, Chernii TV, Fokina DO. Nevrolohichni proiavy Long-COVID. Pryntsypy likuvannia. Metodychni rekomendatsii [Neurological manifestations of Long-COVID. Principles of treatment. Methodological recommendations]. Kyiv: DNU "Naukovo-praktychnyi tsentr profilaktychnoi ta klinichnoi medytsyny"; 2022. Ukrainian.
Gudowska-Sawczuk M, Mroczko B. The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review. J Clin Med. 2021;10(13):2772. doi: https://doi.org/10.3390/jcm10132772
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. doi: https://doi.org/10.1016/S0140-6736(20)30566-3. Erratum in: Lancet. 2020;395(10229):1038. doi: https://doi.org/10.1016/S0140-6736(20)30606-1. Erratum in: Lancet. 2020;395(10229):1038. doi: https://doi.org/10.1016/S0140-6736(20)30638-3
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-90. doi: https://doi.org/10.1001/jamaneurol.2020.1127
Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol. 2021;268(9):3059-71. doi: https://doi.org/10.1007/s00415-021-10406-y
Dziak L, Tsurkalenko O, Chekha K, Suk V. [Modern Aspects of Neuropathogenesis and Neurological Manifestations of COVID-19]. International Neurological Journal. 2021;17(2):6-15. Ukrainian. doi: https://doi.org/10.22141/2224-0713.17.2.2021.229887
Fernández-de-Las-Peñas C, Navarro-Santana M, Gómez-Mayordomo V, Cuadrado ML, García-Azorín D, Arendt-Nielsen L, et al. Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: A meta-analysis of the current literature. Eur J Neurol. 2021;28(11):3820-5. doi: https://doi.org/10.1111/ene.15040
Nannoni S, de Groot R, Bell S, Markus HS. Stroke in COVID-19: A systematic review and meta-analysis. Int J Stroke. 2021;16(2):137-49. doi: https://doi.org/10.1177/1747493020972922
Volos L, Stoliar H, Mykhaylichenko T. Pathomorphological changes of the brain in patients with COVID-19. J Neurol Sci. 2021;429:119837. doi: https://doi.org/10.1016/j.jns.2021.119837
Belani P, Schefflein J, Kihira S, Rigney B, Delman BN, Mahmoudi K, et al. COVID-19 Is an Independent Risk Factor for Acute Ischemic Stroke. AJNR Am J Neuroradiol. 2020;41(8):1361-4. doi: https://doi.org/10.3174/ajnr.A6650
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 L. I. Volos, H. L. Stoliar
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
